Tangfeng Lv, MD (Respiratory Medicine)

Department of Respiratory Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China

Dr. Lv is an Associate Professor of Medicine at Nanjing University in the Department of Respiratory Medicine of Jinling Hospital. He is engaged in the thoracic medical oncology research program and has authored or co-authored over 50 medical articles on thoracic malignancies. He studied in Nanjing University as an candidate MD. with a major in lung cancer and then went to Jinling Hospital as a postdoctoral fellow in Nanjing. Dr. Lv focuses on clinical research in thoracic malignancies. He is the sub-principal investigator of the Chinese lung cancer intergroup trial that is studying the potential role of IBI305 and IBI308 in anti-angiogenesis therapy and immune checkpoint therapy in addition to advanced non-small cell lung cancer. Additional areas of interest include pathogenesis of lung cancer and predictive biomarkers focused on lincRNAs, Circular RNAs and CeRNAs. He also does population science research looking at female patients in lung cancer. He serves on the lung cancer academic group and is the secretary of the medical association of Jiangsu Province.